In:
Hemodialysis International, Wiley, Vol. 26, No. 3 ( 2022-07)
Abstract:
Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone‐induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion.
Type of Medium:
Online Resource
ISSN:
1492-7535
,
1542-4758
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
2103570-2
Permalink